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The diagnosis or exclusion of cancer in the thyroid nodule remains 
a clinical dilemma for general surgeons and endocrinologists. 
Nodular disease of the thyroid is very common, while cancer is 
rare; a definite diagnosis of either is difficult to make. The general 
prevalence of thyroid nodules is very high. They are detectable in 
5% of the normal population on clinical examination,[1,2] in over 
48% on high-resolution ultrasound,[3] and in over 50% at autopsy. [4] 
The widespread use of imaging means that many incidental 
thyroid nodules requiring evaluation are detected.
In contrast, thyroid cancer remains a rare disease, with an 
incidence of only 1 - 2/100 000 population per year.[5] Papillary 
carcinoma and follicular carcinoma remain the most common 
histological subtypes, and in general have very good long-term 
prognosis and survival rates.[6] Poor prognosis and shorter survival 
in thyroid cancer are associated with the rare and aggressive 
anaplastic and medullary histological subtypes,[7] which are 
relatively easy to diagnose pre-operatively.
A confident pre-operative diagnosis of thyroid cancer greatly 
facilitates appropriate surgical intervention, decreases unnecessary 
surgery, and is safer for patients. Recent advances in the use of 
ultrasound and fine-needle aspiration biopsy (FNAB) have resulted 
in improved pre-operative diagnosis of nodules in many centres.[8,9] 
These advances include defining ultrasound features that predict 
malignancy, increased use of ultrasound-guided FNAB (US-FNAB), 
and standardised reporting of cytopathological specimens.
Surgeons doing thyroid surgery at our institution noted that 
advances in ultrasound and cytology reporting were not consistently 
applied in the evaluation of thyroid nodules. We undertook this 
study to evaluate this impression by looking at the correlation 
between pre-operative investigations and final diagnosis.
Methods
A retrospective collection of data on all patients diagnosed with 
thyroid carcinoma from 2004 to 2010 from a single institution was 
done. The patients were identified from the oncology, pathology 
and surgical records. The pre-operative clinical assessment, 
ultrasound and FNAB results were correlated with the final 
histological findings. A standardised confidential proforma was 
used to retrospectively capture the data from patients’ records.
Ultrasound results were recorded as suspicious if any feature 
known to be predictive of malignancy was reported. These 
included microcalcifications, hypo-echoic echogenicity, increased 
vascularity and pathological cervical lymph nodes. Irregular 
margin and shape were not recorded in any ultrasound results.
FNAB was done using palpation alone for all solitary nodules 
and with ultrasound guidance in multinodular goitres. Biopsy 
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Aim. Ultrasonography and ne-needle aspiration biopsy (FNAB) are the mainstays of diagnosing thyroid cancer accurately and reducing 
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e majority (99, 90.8%) had well-dierentiated thyroid cancers (56 
papillary, 30 follicular, 10 mixed and 3 Hurtle cell carcinomas). ere were 6 anaplastic and 4 medullary carcinomas. Of the 109 patients 38 
had a denite pre-operative diagnosis, in 61 a malignant tumour was suspected, and 10 had surgery for benign disease. FNAB was inadequate 
in 11 cases and the ndings indicated a benign lesion in 47, a suspicious lesion in 13 and a malignant lesion in 38 patients diagnosed with 
thyroid carcinoma. FNAB diagnosed all patients with medullary and anaplastic carcinoma but less than half of those with well-dierentiated 
thyroid carcinoma. Ultrasound scans detected at least one suspicious feature in 44 patients. Microcalcication was the most common sign.
Conclusion. e rate of pre-operative diagnosis of well-dierentiated thyroid carcinomas in this unit is under 50%, well below international 
norms. Our standard practice needs to change to include ultrasound-guided FNAB and standardised reporting of high-resolution ultrasound 
and cytology, before reassessment of our diagnostic accuracy.
S Afr J Surg 2013;51(2):46-49. DOI:10.7196/SAJS.1261
VOL. 51    NO. 2     may 2013      SAJS          47
reports were recorded as indicating a benign 
lesion if colloid, macrophages and follicular 
cells were reported, and as suspicious for 
follicular carcinoma if a microfollicular 
pattern with cellular overlapping or a 
predominance of Hurtle cells was seen. 
Features suspicious for papillary carcinoma 
included the presence of some features 
of papillary carcinoma (cytoplasmic 
grooves, large nuclei and prominent 
nucleoli, cellular inclusions resulting in an 
‘Orphan Annie’ appearance, and calcified 
psammoma bodies), but were insufficient 
to make the diagnosis. Malignant cytology 
was recorded if the pathologist reported 
a confident diagnosis of malignancy. The 
final evaluation of the indication for surgery 
as assessed by the consultant surgeon was 
recorded as thyroid carcinoma, suspicious 
multinodular goitre/solitary nodule, or 
benign thyroid pathology. Patients with 
malignant lesions diagnosed on lobectomy 
underwent completion thyroidectomy if the 
tumour size was >1 cm in diameter.
Results
Final histopathology reports showed that 
a total of 109 patients, 79 female and 30 
male, were diagnosed with thyroid cancer. 
The majority (99, 90.8%) had well-
differentiated thyroid cancers (56 papillary, 
30 follicular, 10 mixed follicular/papillary 
and 3 Hurtle cell carcinomas). There were 
6 anaplastic and 4 medullary thyroid 
carcinomas. The majority of the patients 
(65%) had solitary nodules.
The outcomes of the pre-operative 
evaluation were as follows.
General risk factors
Most patients did not have any risk factors 
on history or physical examination. Only 
1 patient had been exposed to radiation, 2 
had a family history of multiple endocrine 
neoplasia II, 2 were aged under 25, and 1 
had a family history of papillary carcinoma. 
Most patients were asymptomatic, only 14 
presenting with symptoms of compression 
due to multinodular goitre and 4 complain-
ing of significant voice changes. Of the 
patients 14 had either metastatic disease or 
clinically detectable lymphadenopathy at 
presentation.
Definite diagnosis of malignancy 
(38 patients)
In 38 cases there was a definite pre-
operative diagnosis of thyroid cancer. 
These cases included all 10 of the patients 
with anaplastic and medullary cancers, 
22/56 papillary cancers and 6/30 follicular 
cancers. Of the 22 definite papillary 
cytology results, 9 were obtained from 
biopsy specimens from metastatic cervical 
lymph nodes. All 6 patients with metastatic 
follicular carcinoma were diagnosed pre-
operatively through biopsy of metastases (2 
lung, 3 bone and 1 lymph node).
Suspicious for malignancy 
(61 patients)
Patients who had suspicious clinical, 
ultrasound or FNAB findings pre-
operatively were placed in this group. Of 61 
patients operated on because of suspicion of 
malignancy, 39 had solitary nodules and 22 
suspicious nodules in a multinodular goitre. 
Forty-six patients underwent a diagnostic 
lobectomy fol lowed by completion 
thyroidectomy at a later date. In 8 patients 
with papillary carcinomas measuring less 
than 1 cm in diameter, the initial lobectomy 
was adequate surgical management. Five 
patients had a primary total thyroidectomy 
as they also had significant compressive 
symptoms, and 2 had on-table frozen 
section of the lobe and immediate total 
thyroidectomy.
Benign diagnosis (10 patients)
In 10 patients the diagnosis of thyroid 
cancer was unexpected. The indication 
for surgery in all these cases was either 
multinodular goitre with compression or 
thyrotoxicosis. Primary total thyroidectomy 
was performed on 3 patients, and 2 required 
completion thyroidectomy. In 5 patients 
lobectomy was adequate surgical treatment 
as the cancers were <1 cm in size.
Fig. 1 summarises these findings accord-
ing to histological sub-type.
Accuracy of fine-needle aspiration 
biopsy
All patients had FNAB performed pre-
operatively. Of the 109 biopsies, 11 
were inadequate and in 47 findings 
were consistent with a benign lesion. 
The benign lesion category included all 
cytological reports of follicular cells with 
colloid and macrophages, which may also 
be described as an indeterminate result. 
All 10 anaplastic and medullary cancers 
were diagnosed confidently on FNA. Of 
the papillary cancers, 13 were positively 
diagnosed by FNA of the thyroid gland and 
the remaining 9 from lymph node biopsies. 
A further 6 results were suspicious. The 
only confident diagnoses of follicular 
carcinoma were made on FNAB of 
metastases. Five FNABs of the thyroid 
were reported as suspicious for follicular 
carcinoma. The accuracy of FNAB in the 
diagnosis of well-differentiated thyroid 
carcinoma is summarised in Table 1. Only 
well-differentiated cancers are represented 
in this table, because 100% of anaplastic 
and medullary cancers were diagnosed 
accurately on pre-operative FNAB.
Accuracy of ultrasound
Ultrasound reports mentioned at least one 
malignant feature in 44 cases; the sensitivity 
of ultrasound scans was therefore 40.4%. 
In our series, there was lack of consistency 
in the quality of ultrasound reporting. Of 
the six commonly reported ultrasound 
signs of malignancy, shape and irregular 
margin were never reported. The reporting 












Fig. 1. Comparison of pre-operative cytology and final histology.
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only 40.4% of nodules that proved to be 
malignant was a suspicious sign reported. 
The commonest suspicious feature reported 
was microcalcifications. The absence of 
suspicious features as an important negative 
was not specifically stated in reports.
Concordance of pre-operative 
investigations
Ultrasound and FNAB together predicted 
malignancy in 24 of the 109 patients 
(22.0%).
Discussion
The general demographics of our group, 
with women predominating, two-thirds 
of nodules being solitary and well-
differentiated carcinoma representing over 
90% of malignancies, are consistent with 
the international experience.[6] Papillary 
carcinoma was the commonest histological 
subtype.  The results of this study 
illustrate the difficulty of diagnosing well-
differentiated thyroid cancer. The lack of a 
single sensitive and specific pre-operative 
diagnostic tool results in a large number of 
diagnostic lobectomies.
High-resolution ultrasound is critical 
in the diagnosis of thyroid lesions. A 
number of ultrasound features that assist 
in predicting the risk of malignancy in 
a nodule have been identified over 
the past 10 - 15 years. These include 
solid versus cystic consistency, hypo-
echogenicity, microcalcifications, shape, 
irregular margin and central/nodular 
vascularity. [10] A wide range of sensitivities 
and specificities is reported for each 
sign, and intense research in this area is 
ongoing. The overall sensitivity reported 
for any one suspicious ultrasound feature 
in large-volume centres is 83 - 93%. [8,11,12] 
In our series the sensitivity for a single 
suspicious feature was 44.7%. This may 
be the result of the large number of 
consultants and trainees who perform 
ultrasounds, and lack of a standardised 
reporting format.
Ultrasound reports of multinodular 
goitres in this series reported on dominant 
nodules, implying the largest nodule. 
However, recent research suggests that size 
is not a factor in predicting malignancy,[13-15] 
and the most ultrasonographical ly 
suspicious nodule and not the largest should 
therefore be identified for biopsy. Work by 
Papini et al.[8] showed that the efficiency 
of using malignant ultrasound features 
to target biopsy in multinodular goitres 
resulted in 21.7% of malignant nodules 
being diagnosed, as opposed to only 5.8% 
when size alone was used. FNAB of the 
largest nodule in a multinodular goitre 
would have represented a sampling error 
and contributed to the high benign false-
negative cytology results in our series.
In 2007, the National Cancer Institute 
hosted a multidisciplinary meeting 
including endocrinologists, pathologists, 
surgeons and radiologists in Bethesda, 
Md.  This  me et ing  pro duce d  t he 
Bethesda System for Reporting Thyroid 
Cytopathology. [16] The Bethesda System 
divides thyroid cytopathology into six 
categories: (i) non-diagnostic; (ii) benign; 
(iii) atypia of unknown significance; 
(iv) follicular lesions; (v) suspicious for 
malignancy; and (vi) malignant.
In other centres, use of this classification 
system has improved the yield rate for 
malignancy from diagnostic thyroid 
surgery from 15% to 50%,[5] resulting in 
a significant reduction in unnecessary 
operations. The accuracy of FNAB is 
reported to range between 80% and 90%,[5] 
although the methodology for generating 
these predictive values varies from series 
to series. Rates of false-negative benign 
results are reported to be between 1% and 
3% in a number of research studies.[9,13,17,18]
In contrast to these high rates of 
accuracy, the sensitivity of FNAB in our 
series was 44.7%. While cytology was 
100% accurate in diagnosing anaplastic 
and medullary carcinomas, performance 
for well-differentiated cancers was poor. 
There was greater accuracy in diagnosing 
papillary carcinoma where cytology was 
positive or suspicious (53.2% of patients). 
For follicular carcinoma, FNAB was only 
suggestive of malignancy in 33.5% of 
patients. Although follicular carcinoma is 
impossible to diagnose on cytology alone, 
a report of a follicular neoplasm (Bethesda 
category 4)[16] would be regarded as a 
positive cytology result indicating prompt 
surgical excision of the lesion.
Multiple factors contributed to the low 
diagnostic yield of FNAB in our series. 
Sampling error played a major role. 
US-FNAB is not standard practice in 
our unit and is only performed where a 
particular nodule in a multinodular goitre 
is reported as suspicious. In addition, 
US-FNAB is often not done by the same 
radiologist who initially diagnosed the 
lesion. Often the largest or dominant 
and not the most ultrasonographically 
suspicious nodule is biopsied. Patients 
considered to have solitary nodules were 
biopsied on palpation alone, which may 
also have resulted in sampling error, 
particularly in complex solid-cystic 
nodules. Finally, prior to conducting this 
study there was no standardised reporting 
of thyroid cytology at our institution, 
making it difficult for treating doctors to 
interpret cytology results.
Conclusion
The results of this study illustrate the 
complexity of thyroid nodule assessment, 
specifically with regard to the diagnosis 
of well-differentiated thyroid cancer. Our 
centre is performing below the standards 
achieved in international multidisciplinary 
units in achieving a pre-operative 
diagnosis to plan therapy better. This study 
details and discusses these deficiencies 
and the probable reasons for them. We 
believe that improved sampling techniques 
using ultrasound, and standardisation of 
ultrasound and cytopathology reporting, 
are the key elements needed to improve 
diagnostic accuracy.





malignancy, n (%) 
Suspicious for 
malignancy, n (%) 
Benign/
indeterminate, n (%)
Papillary (n=56) 22 (39.3) 6 (10.7) 28 (50.0)
Follicular (n=33) 6 (18.2) 5 (15.2) 22 (66.7)
Mixed (n=10) 0 (0) 2 (20.0) 8 (80.0)
Total (N=99) 28 (28.3) 13 (31.1) 58 (58.6)
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